Top Quantum Computing Stocks 2026: Uncle Sam Just Bought In

Here's the weird thing about quantum computing in 2026.

The technology had its best year ever. The stocks had one of their worst.

Revenue is exploding. IonQ did $80 million in a single quarter, up 287% year over year.^[1] Infleqtion doubled. Rigetti nearly tripled. Quantinuum went public in June and raised $1.68 billion, the biggest quantum listing in history.

And on May 21, the U.S. Department of Commerce did something it has never done before: it handed $2 billion of CHIPS Act money to nine quantum companies... and took an equity stake in every one of them.^[2]

Meanwhile, the pure-play stocks lost roughly half their value from June to early August. Then bounced 20% in a week. Then fell again when Treasury yields hit 4.7%.

So what's actually going on?

Quantum is real: machines are being sold, installed, and used in production. It's also still years from paying for itself. Every company on this list burns more cash than it makes, and most will sell more stock to keep going.

The one milestone everyone is watching: verified quantum advantage. That's the point where a quantum computer does something useful that the best classical supercomputer provably cannot. IBM's CEO said it would happen in 2026. In late July, IBM and partners posted three claims to the public Quantum Advantage Tracker.^[3] Classical-simulation researchers are now trying to knock them down. If the claims survive, the whole sector re-rates. If they don't, we've been here before.

We're slicing this sector by where a company sits in the stack:

• Pure-plays build the quantum computers themselves. Highest upside, highest dilution risk.
• Picks-and-shovels sell what every quantum company needs: chips, software, and the glue between quantum and classical machines.
• Integrated giants fund quantum from a profitable core business. You get the option without the blowup risk.
• Private bellwethers you can't buy yet, but whose IPOs will move everything else.

These are the companies building the actual quantum computers. When the sector rallies, they go up 30% in a week. When it sells off, they lose half. Size accordingly.

IonQ NYSE: IONQ

IonQ is the revenue king, and it isn't close. Q2 revenue was $80.1 million, up 287%, and management raised full-year guidance to $280–290 million. Remaining performance obligations (contracted revenue not yet booked) grew 297%. That's five straight record quarters.

The big move in July: IonQ closed its $1.8 billion purchase of SkyWater Technology, a U.S. semiconductor foundry. Now IonQ makes its own chips. Management calls it the only vertically integrated, full-stack quantum platform. Skeptics call it an expensive way to buy revenue.

Here's the catch. Adjusted EBITDA loss was $120 million in one quarter. Stock-based comp was $142 million. GAAP net loss was $1.87 billion, mostly a non-cash warrant revaluation because the stock went up, but still an ugly headline. IonQ was notably not in the Commerce Department's $2 billion deal, and a short-seller report in February accused it of overstating its government pipeline. The stock has a beta over 3. It closed near $40 after earnings, well off its June high near $69. Investor day is September 8 at the NYSE.

Quantinuum NASDAQ: QNT

Quantinuum is the new kid, and the one the scientists respect most. It IPO'd June 4 at $60 a share, raised $1.68 billion, and now trades around $54 with a market cap near $14 billion.

Why the respect? Fidelity. Quantinuum's Helios system demonstrated near "five nines" (99.999%) logical fidelity in Q2, which is the metric that decides whether error correction actually works. Its ion-trap machines are the ones IBM's rivals benchmark against.

Q2 revenue was $8 million, up 279%, and 2026 guidance was raised to $28–32 million. Oracle signed a multi-year deal to put Helios on Oracle Cloud, including buying a system outright. Quanta Computer signed on to help manufacture future systems. The government took a $100 million equity stake.

The risk is math. A $14 billion valuation on $30 million of revenue is about 470x sales. The company says it won't be free-cash-flow positive until 2030, with its next-gen Apollo machine due in 2029. Honeywell and Cambridge Quantum still own the vast majority, and lockups expire this winter. Analysts have a $97 average target.

Rigetti Computing NASDAQ: RGTI

Rigetti is the cheapest way to own a superconducting quantum company with its own chip fab.

Q2 revenue was $5.1 million, up 183%, on sales of its 9-qubit Novera systems. Its flagship, the 108-qubit Cepheus-1, is built from twelve 9-qubit chiplets tiled together, the largest modular quantum computer on the market. It runs at 99.1% two-qubit gate fidelity; the target is 99.5% by year-end, and 99.9% on a ~1,000-qubit system in about three years.

The balance sheet is the story: $541 million in cash, zero debt, and a letter of intent for up to $100 million more from Commerce over three years. Operating loss is a manageable $28 million a quarter. Rigetti can fund its roadmap without begging the market.

The knock: revenue is tiny and lumpy, and the stock fell 22% in July as investors got bored waiting. Around $17 in late August, down about 23% for the year. If the fidelity target lands, that changes.

D-Wave Quantum NYSE: QBTS

D-Wave is the only company on this list whose customers run quantum applications in production, today, on a real problem. AT&T cut a network-optimization job from an hour to under 15 seconds. NTT DOCOMO just deployed its second production app.

The reason is annealing. D-Wave's Advantage2 machine (4,400+ qubits) doesn't do general-purpose quantum computing; it does optimization problems, and it does them now. Purists sniff. Customers pay. First-half 2026 bookings hit $35.5 million versus $2.9 million a year earlier, anchored by a $20 million system sale to Florida Atlantic University and a $10 million deal with a Fortune 100 company.

In January, D-Wave bought Quantum Circuits for $550 million to get into gate-model computing too, with a roadmap to 100 logical qubits by 2032. Commerce is taking a $100 million equity stake.

Two warnings. First, Q2 revenue was only $3.1 million, a miss, because system sales take time to recognize. Second, D-Wave's 2025 "quantum supremacy" paper was partly matched by a classical algorithm in May. The CFO retired on August 25 with an interim replacement. Stock around $21, down about 26% this year, with the most lopsided bullish analyst coverage in the group.

Infleqtion NYSE: INFQ

Infleqtion is the pure-play that already has a business. It sells quantum sensors (atomic clocks, gravimeters) to defense and aerospace customers, and that revenue funds its neutral-atom quantum computer.

Q2 revenue was $12.6 million (later revised up to $13.5 million), up 116%, all organic. Full-year guidance is about $45 million. That's more revenue than Rigetti and D-Wave combined. It ended the quarter with $582 million in cash and no debt, plus a $100 million Commerce LOI.

On the computing side, the target is 30 logical qubits this year. It hired a Lockheed Martin senior fellow to run the effort.

It went public via SPAC in February and promptly fell 30%. Now around $13. Operating losses tripled year over year as it spends on three new facilities. Also: it filed a late 10-Q in August to restate revenue timing on two government contracts. No cash impact, but it's the kind of thing you watch.

Xanadu Quantum Technologies NASDAQ: XNDU

Xanadu is the only public pure-play photonic quantum company. Photons run at room temperature and travel over fiber, which makes them the natural bet for networking quantum computers together. Nvidia is a partner. So are AMD, Lockheed Martin, and TELUS.

It listed in March via SPAC, and Canada and Ontario are negotiating up to C$390 million to build photonic manufacturing near Toronto. In Q2 it cut its edge-coupling optical loss to 0.085 dB, which matters because photon loss is the whole ballgame for this modality.

Cash was $313 million at quarter-end, but Xanadu signed a $300 million at-the-market facility with Yorkville in May and has already started drawing on it. Lowest-profile name here, highest technical risk, and the one that benefits most if photonics wins.

You don't have to guess which qubit wins. You can own what all of them buy.

Nvidia NASDAQ: NVDA

Nvidia doesn't make a quantum chip, just everything around one. NVQLink connects quantum processors directly to GPUs; 17 quantum companies and eight national labs adopted it at launch. CUDA-Q is the software layer that runs on about three-quarters of publicly available quantum processors. And in April, Nvidia released open-source AI models (Ising) for quantum error correction, which sent the whole sector up.

Quantum is a rounding error on Nvidia's income statement. But if hybrid quantum-classical supercomputers happen, they run through Nvidia. That's the lowest-risk quantum exposure on this list.

Quantum Computing Inc NASDAQ: QUBT

QCi runs a thin-film lithium niobate photonic chip foundry in Tempe, Arizona, and it's been on an acquisition spree: three deals in 2026, the latest a $73 million purchase of packaging foundry NHanced Semiconductors to launch a second fab. Q2 revenue was $5.6 million, up from $61,000 a year ago (yes, thousand). It has about $1.3 billion in cash.

Trust is the problem. Roughly 70–80% of revenue is government subcontract work. Short-sellers have repeatedly disputed the company's performance claims, and a chunk of the "quantum" here is really conventional photonics. The stock ran hard on the revenue headline, then gave back 7% in a day. Around $8. Treat the foundry as the asset and the quantum story as the marketing.

Horizon Quantum NASDAQ: HQ

Horizon builds software that runs on anyone's quantum hardware: its Triple Alpha platform and Beryllium programming language. The pitch is Windows for quantum. Whichever qubit wins, the software still sells.

It's tiny. Q1 net loss was $3.6 million on almost no revenue, with about $97 million in cash after its March SPAC. It's building two testbeds, one in Singapore and a 256-qubit trapped-ion system in Dublin. The stock is around $19, down from a $45 high. This is a lottery ticket on quantum software, and you should size it like one.

Big companies that fund quantum from cash flow. You give up the 5x upside. You also give up the 50% drawdowns.

IBM NYSE: IBM

IBM has more quantum computers deployed than anyone (90+ systems), the clearest roadmap in the industry, and now $1 billion from Commerce plus $1 billion of its own to launch Anderon, a standalone quantum chip foundry in Albany, New York. In June it pledged over $10 billion to quantum over five years. In July it bought HRL Laboratories to add silicon-spin qubits to the foundry's menu.

The roadmap: Nighthawk (120 qubits) now, Kookaburra this year, Cockatoo in 2027, and Starling in 2029, a fault-tolerant machine with 200 logical qubits running 100 million gates. IBM is also the company that said verified quantum advantage would arrive in 2026, and it's the one that posted three claims in late July.

Quantum is small next to IBM's software and consulting businesses. But if you want to own the company most likely to make the advantage headline, this is it.

Alphabet NASDAQ: GOOGL

Google's Willow chip produced the first "verifiable quantum advantage" claim in October 2025, running its Quantum Echoes algorithm 13,000x faster than the best classical estimate. In March 2026 it added neutral atoms as a second modality alongside superconducting, hedging the space-time tradeoff between the two.

You're buying a search and cloud company with a world-class quantum lab attached.

Honeywell NASDAQ: HON

Honeywell still owns most of Quantinuum after the IPO. If you want QNT exposure without the 3.6 beta, this is the side door. (It also remains a strategic Quantinuum customer.)

The government took equity in nine quantum companies. Three of them, you can't buy yet. Their IPOs will reset comps for everyone above.

PsiQuantum (Private)

The biggest private bet in quantum: a million-qubit photonic computer built on standard semiconductor manufacturing. Valued at $7 billion after a September 2025 Series E, with $1.67 billion raised, plus a $100 million Commerce equity stake and an AU$940 million commitment from Australia. It broke ground on utility-scale sites in Chicago and Queensland, targeting operational systems in 2027.

No IPO filing. Secondary markets price shares around $28–30. But with Quantinuum's listing as a template, and Uncle Sam on the cap table, the pressure to list is rising.

Atom Computing (Private)

Neutral-atom qubits, a $100 million Commerce equity stake, and a deep Microsoft partnership on logical qubits. It's been quiet on IPO plans, but it was named in reports alongside Rigetti and D-Wave as an early candidate for the government-equity program. Watch for a filing after Infleqtion (its closest public comp) stabilizes.

QuEra (Private)

The other neutral-atom leader, spun out of Harvard and MIT, with Nvidia among its backers and an NVQLink partner. It wasn't part of the Commerce deal, which makes it the odd one out among the neutral-atom trio. No IPO chatter yet.

Failure mode one: the advantage claims don't hold up. Every "we beat classical" claim in quantum history has been chased by a classical algorithm that closed the gap. Google's 2019 result got matched. D-Wave's 2025 result got partly matched in May 2026. IBM's July claims are on a public tracker specifically so people can try. If the classical-simulation crowd wins again, the 2026 narrative collapses and the pure-plays get cut in half. Again. Watch the Quantum Advantage Tracker, and any preprint with "efficient classical simulation" in the title.

Failure mode two: dilution outruns progress. These companies burn between $30 million and $120 million a quarter. IonQ, Xanadu, and QCi all have at-the-market or warrant structures. Quantinuum's lockup expires this winter. The government stakes were paid for with new shares. Even if the technology works, you may own a much smaller piece of it by the time it does. Watch the share count in every 10-Q, not just revenue. And watch 10-year Treasury yields: at 4.7%, long-duration growth stocks get no mercy.

The next 12–18 months are unusually dense with dates.

• September 8: IonQ investor day at the NYSE. First full look at the SkyWater integration and the semiconductor-based QPU roadmap.
• Q4 2026: Rigetti's 99.5% fidelity target on Cepheus-1. Infleqtion's 30-logical-qubit target. D-Wave's first gate-model system and FAU installation. IBM's next Nighthawk (7,500 gates) and Kookaburra.
• Winter 2026–27: Quantinuum lockup expiry. Commerce equity deals move from letters of intent to definitive agreements (and the shares get issued).
• 2027: IBM Cockatoo, the first multi-chip entangled processor. PsiQuantum's target for operational utility-scale systems. Probable IPO window for PsiQuantum and Atom Computing.
• Ongoing: the Quantum Advantage Tracker. Each claim that survives a few months of classical attack is worth more than any earnings beat.

Revenue keeps compounding, the government keeps writing checks, and the stocks keep swinging 30% a month. The companies with cash and customers (IonQ, Quantinuum, Infleqtion, D-Wave) can ride that out. The ones with only a roadmap (Horizon, Xanadu) need the advantage headline to land.

If it lands, the whole list goes up together. If it doesn't, the picks-and-shovels and integrated names are where you'll be glad you hid.